ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 215721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 215721; 2) Community: the network communities that were significantly associated with the response to NSC 215721; 3) Molecule: the relationships between components within communities and NSC 215721; 4) MDR: the compounds that were significantly associated with the NSC 215721.

NSC Compound Enrichment Correlation
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0267520285931239 0.24607676
NSC 149765 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) 0.0267520285931239 -0.043783495
NSC 15795 Null 0.0267520285931239 -0.095225123
NSC 175493 Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- 0.0267520285931239 0.0012238589
NSC 241240 Carboplatin 0.0267520285931239 0.22577157
NSC 28608 Null 0.0267520285931239 0.44294319
NSC 31780 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) 0.0267520285931239 0.1468516
NSC 326061 1-Piperidinecarbothioic acid, 2-ethyl-, [1-(2-pyridinyl)ethylidine]hydrazide 0.0267520285931239 0.38855975
NSC 346098 Null 0.0267520285931239 0.088018486
NSC 618770 Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide 0.0267520285931239 0.19644518
Total:76  Current:42    [First] [Prev] [Next] [Last]